Chemokine Receptors Expression in MSCs: Comparative Analysis in Diff erent Sources and Passages

다국어 초록 (Multilingual Abstract)

MSC-based therapy is providing a cure for degenerative diseases with unmet medical need and usually iliac crest bone marrow (ICBM) are being applied in clinics. Alternative sources, including adipose tissue and reamer/irrigator/ aspirator hold great potential for isolating MCSs. Here, we compared original MSCs features of adipose tissue (Ad-MSCs) and bone marrow of long-bone (RIA-MSCs) or iliac crest, and the expression of chemokine receptors (including CXCR4, CX3CR1, CXCR6, CXCR2, CCR1 and CCR7) in these three sources, which are important in the context of homing. We further investigated the role of SDF-1/CXCR4 axis as a key player in motility of different population of MSCs using Transwell migration assay. All cells exhibited typical MSCs characteristics. However, different MSCs sources expressed different levels of chemokine receptors. Generally, the expression of these chemokine receptors was decreased with increasing passage (P) number from 2 to 3. Interestingly, it was observed that the CXCR4 expression and migration capacity in Ad-MSCs is significantly higher than ICBM and RIA-MSCs in P2. Although our data showed that CXCR4 had highest expression in P2 Ad-MSCs, but it dramatically declined following sub-culturing in the P3. Hence, to improve homing of MSCs by means of chemokine/their receptors axis, the source of isolation and passage number should be considered for clinical applications.

참고문헌 (Reference)

1 Wu S, "Ultrasoundtargeted stromal cell-derived factor-1-loaded microbubble destruction promotes mesenchymal stem cell homing to kidneys in diabetic nephropathy rats" 9 : 5639-, 2014

2 Wang G, "Transfection of CXCR-4 using microbubble-mediated ultrasound irradiation and liposomes improves the migratory ability of bone marrow stromal cells" 15 : 21-31, 2015

3 Ringe J, "Towards in situ tissue repair : human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2" 101 : 135-146, 2007

4 Andreas K, "Toward in situ tissue engineering : chemokine-guided stem cell recruitment" 32 : 483-492, 2014

5 Mirahmadi M, "Therapeutic potential of Stem Cell Preconditioning for Ischemic Heart Diseases/Letter to the Editor" 5 : 92-93, 2013

6 Cox G, "The use of the reamer-irrigator-aspirator to harvest mesenchymal stem cells" 93 : 517-524, 2011

7 Ponte AL, "The in vitro migration capacity of human bone marrow mesenchymal stem cells : comparison of chemokine and growth factor chemotactic activities" 25 : 1737-1745, 2007

8 Ma HC, "Targeted migration of mesenchymal stem cells modified with CXCR4 to acute failing liver improves liver regeneration" 20 : 14884-, 2014

9 Kortesidis A, "Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells" 105 : 3793-3801, 2005

10 Friedenstein AJ, "Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues : cloning in vitro and retransplantation in vivo" 17 : 331-340, 1974

11 Naderi-Meshkin H, "Strategies to improve homing of mesenchymal stem cells for greater efficacy in stem cell therapy" 39 : 23-34, 2015

12 Romanov YA, "Searching for alternative sources of postnatal human mesenchymal stem cells : candidate MSC-like cells from umbilical cord" 21 : 105-110, 2003

13 Naderi H, "Review article : critical issues in tissue engineering : biomaterials, cell sources, angiogenesis, and drug delivery systems" 26 : 383-417, 2011

14 Shi M, "Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment : role in homing efficiency in NOD/SCID mice" 92 : 897-904, 2007

15 Shi C, "Recent progress toward understanding the physiological function of bone marrow mesenchymal stem cells" 136 : 133-138, 2012

16 Henrich D, "RIA reamings and hip aspirate: a comparative evaluation of osteoprogenitor and endothelial progenitor cells" 41 : S62-S68, 2010

17 Nguyen B, "Pulsed focused ultrasound enhances mesenchymal stem cell homing to skeletal muscle in a murine model of muscular dystrophy and homing was suppressed by Ibuprofen" 3 : P69-, 2015

18 Kavanagh DP, "Pretreatment of mesenchymal stem cells manipulates their vasculoprotective potential while not altering their homing within the injured gut" 33 : 2785-2797, 2015

19 Porter RM, "Osteogenic potential of reamer irrigator aspirator(RIA)aspirate collected from patients undergoing hip arthroplasty" 27 : 42-49, 2009

20 Chamberlain G, "Murine mesenchymal stem cells exhibit a restricted repertoire of functional chemokine receptors: comparison with human" 3 : e2934-, 2008

21 Secco M, "Multipotent stem cells from umbilical cord: cord is richer than blood" 26 : 146-150, 2008

22 Hoogduijn MJ, "Mesenchymal stromal cells for organ transplantation: different sources and unique characteristics" 19 : 41-46, 2014

23 Keating A, "Mesenchymal stromal cells : new directions" 10 : 709-716, 2012

24 Heirani-Tabasi A, "Mesenchymal stem cells; defining the future of regenerative medicine" 1 : 34-39, 2015

25 Ru¨ster B, "Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells" 108 : 3938-3944, 2006

26 Ryan JM, "Mesenchymal stem cells avoid allogeneic rejection" 2 : 8-, 2005

27 Satija NK, "Mesenchymal stem cell-based therapy : a new paradigm in regenerative medicine" 13 : 4385-4402, 2009

28 Karp JM, "Mesenchymal stem cell homing : the devil is in the details" 4 : 206-216, 2009

29 Miao Z, "Isolation of mesenchymal stem cells from human placenta : comparison with human bone marrow mesenchymal stem cells" 30 : 681-687, 2006

30 Jones EA, "Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells" 46 : 3349-3360, 2002

31 Naderi-Meshkin H, "Injectable hydrogel delivery plus preconditioning of mesenchymal stem cells : exploitation of SDF-1/CXCR4 axis towards enhancing the effi-cacy of stem cells’ homing" 40 : 730-741, 2015

32 Bortolotti F, "In vivo therapeutic potential of mesenchymal stromal cells depends on the source and the isolation procedure" 4 : 332-339, 2015

33 Tang YL, "Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression" 104 : 1209-1216, 2009

34 Al-Nbaheen M, "Human stromal(mesenchymal)stem cells from bone marrow, adipose tissue and skin exhibit differences in molecular phenotype and differentiation potential" 9 : 32-43, 2013

35 Wenisch S, "Human reaming debris : a source of multipotent stem cells" 36 : 74-83, 2005

36 Croitoru-Lamoury J, "Human mesenchymal stem cells constitutively express chemokines and chemokine receptors that can be upregulated by cytokines, IFN-b, and copaxone" 27 : 53-64, 2007

37 Honczarenko M, "Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors" 24 : 1030-1041, 2006

38 Lu¨ttichau IV, "Human adult CD34-progenitor cells functionally express the chemokine receptors CCR1, CCR4, CCR7, CXCR5, and CCR10 but not CXCR4" 14 : 329-336, 2005

39 Kallmeyer K, "Homing properties of mesenchymal stromal cells" 15 : 477-479, 2015

40 Burk J, "Growth and differentiation characteristics of equine mesenchymal stromal cells derived from different sources" 195 : 98-106, 2013

41 Bobis-Wozowicz S, "Genetically modified adipose tissuederived mesenchymal stem cells overexpressing CXCR4 display increased motility, invasiveness, and homing to bone marrow of NOD/SCID mice" 39 : e684-, 2011

42 Park JS, "Engineering mesenchymal stem cells for regenerative medicine and drug delivery" 84 : 3-16, 2015

43 Stolzing A, "Effect of age and diabetes on the response of mesenchymal progenitor cells to fibrin matrices" 2011 : 1-9, 2011

44 Mirzamohammadi S, "Effect of 17b-estradiol on mediators involved in mesenchymal stromal cell trafficking in cell therapy of diabetes" 17 : 46-57, 2015

45 Kim SW, "Dexamethasone and hypoxia upregulate CXCR4 expression in myeloma cells" 50 : 1163-1173, 2009

46 Najafi R, "Deferoxamine preconditioning potentiates mesenchymal stem cell homing in vitro and in streptozotocindiabetic rats" 13 : 959-972, 2013

47 Lapidot T, "Current understanding of stem cell mobilization : the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells" 30 : 973-981, 2002

48 Phinney DG, "Concise review : mesenchymal stem/multipotent stromal cells : the state of transdifferentiation and modes of tissue repair—current views" 25 : 2896-2902, 2007

49 Bara JJ, "Concise review : bone marrow-derived mesenchymal stem cells change phenotype following in vitro culture : implications for basic research and the clinic" 32 : 1713-1723, 2014

50 Li X, "Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation and differentiation" 34 : 695-704, 2014

51 Balasubramanian S, "Comparison of chemokine and receptor gene expression between Wharton’s jelly and bone marrowderived mesenchymal stromal cells" 14 : 26-33, 2012

52 Bahrami AR, "Comparative analysis of chemokine receptor’s expression in mesenchymal stem cells derived from human bone marrow and adipose tissue" 44 : 178-185, 2011

53 Irfan-Maqsood M, "Commercialization of stem cell therapeutic research: bridging a big gap" 1 : 40-45, 2015

54 Naderi-Meshkin H, "Chitosan-based injectable hydrogel as a promising in situ forming scaffold for cartilage tissue engineering" 38 : 72-84, 2014

55 Rankin SM, "Chemokines and adult bone marrow stem cells" 145 : 47-54, 2012

56 Maijenburg MW, "Cell cycle and tissue of origin contribute to the migratory behaviour of human fetal and adult mesenchymal stromal cells" 148 : 428-440, 2010

57 Sordi V, "Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets" 106 : 419-427, 2005

58 Gimble J, "Adipose-derived adult stem cells : isolation, characterization, and differentiation potential" 5 : 362-369, 2003

59 He H, "Activation of protein kinase C e enhanced movement ability and paracrine function of rat bone marrow mesenchymal stem cells partly at least independent of SDF-1/CXCR4 axis and PI3 K/AKT pathway" 8 : 188-, 2015

60 Wynn RF, "A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow" 104 : 2643-2645, 2004